Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer
Noriko Hirai(Asahikawa Medical University), Takaaki Sasaki(Asahikawa Medical College Hospital)
Cited by 11
Related Papers
Administration of VEGF receptor tyrosine kinase inhibitor increases VEGF production causing angiogenesis in human small-cell lung cancer xenografts
|International Journal of Oncology|1992|15
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A
|npj Precision Oncology|2025|1